This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Wednesday's Health Winners & Losers

St. Jude Medical's (STJ) shares gained 2.6% to $39.69 leading up to the company's quarterly earnings report slated for Thursday. A.G. Edwards analyst Jan Wald expects higher earnings in the third and fourth quarters, thanks to the company's new sales force.

Isis Pharmaceuticals (ISIS) gained 2.6% to $10.67 after the company announced a private placement of its $125 million offering convertible subordinated notes due 2027. The company is also issuing an additional $37.5 million in notes at the initial purchasers' option.

Lexicon Genetics (LEXG) shares gained 2.4% to $3.42 after the company said it's initiating a trial on a proposed treatment for irritable bowel syndrome and other gastrointestinal disorders. The drug, dubbed LX1031, will be tested for safety and efficacy in approximately 40 healthy volunteers.

Shares of Affymax (AFFY) gained 5.9% to $34.96 after analysts at RBC Capital Markets and Cowen & Co. initiated coverage of the stock with outperform ratings. According to Cowen analyst Phil Nadeau, data on the company's drug Hematide show the drug is effective and safe. Nadeau expects the drug to enter the market as a treatment for kidney disease patients in 2010 and to treat cancer-related anemia in late in 2011.

Among other health stock winners Wednesday were Pfizer (PFE), 1.3% higher to $26.71; Emergent BioSolutions (EBS), gaining 8.6% to $17.38; NitroMed (NTMD), soaring 14.7% to $3.43; Novogen (NVGN), up 1.1% to $12.37; Cubist Pharmaceuticals (CBST), rising 2.6% to $18.06; and Introgen Therapeutics (INGN), whose shares were boosted 8.7% to $5.51.

Among the losers were The Medicines Co. (MDCO), falling 3.6% to $29.33; Trinity Biotech (TRIB), off 1% to $9.19; Geron (GERN), 1.3% higher to $8.42 and Novo Nordisk (NVO), down 1.2% to $84.80.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,614.81 +215.14 1.31%
S&P 500 1,941.28 +37.27 1.96%
NASDAQ 4,419.4780 +103.4040 2.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs